44.70
+2.17%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Formosa Laboratories
Its shares trade on Taiwan Stock Exchange under the ticker 4746.TW. It has been listed since 27 November 2009. In the fiscal year to 31 December 2025, it reported revenue of TWD 4.85bn and net income of TWD 441.1m. At that date it held total assets of TWD 13.83bn and shareholders' equity of TWD 7.76bn.
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 27 Nov 2009
- Website
- formosalab.com ↗
Leadership
Pay as last reported
- Mr. Josh LinDeputy General Manager-Engineering Division
- Mr. Cheng-Yu ChengChairman of the Board, General Manager, since 1996
- Mr. C.P. YangChief Executive Officer
- Ms. Michelle LoDeputy General Manager-Finance Division, Head of Corporate Governance
- Mr. Hank ChenDeputy General Manager-Production and Environment & Health & Safety Division
- Mr. Hengui HuangDeputy General Manager-Quality Assurance Division
- Mr. Kevin LeeDeputy General Manager-Research & Development Division
- Mr. Chien Hsing LinDeputy General Manager-Legal & Strategy Planning Division
- Ms. Jessica LiouDeputy General Manager-Marketing & Sales Division
- Mr. Jeff SungDeputy General Manager-Injectable Division
- Mr. J.C. WungDeputy General Manager-Quality Control Division
- Ms. Fannie YangDeputy General Manager-Operational Support Division
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Formosa Laboratories Inc has a strong track record of delivering high-quality pharmaceutical products to the market. Their well-established reputation for excellence has garnered trust from customers and partners alike.
- The company boasts a highly skilled and experienced team of professionals who consistently contribute to the innovation and development of new drugs. Formosa Laboratories Inc's robust research and development capabilities enable them to stay competitive in the rapidly-evolving pharmaceutical industry.
Weaknesses
- Despite their strengths, Formosa Laboratories Inc faces certain weaknesses. One of the notable weaknesses is their limited geographical presence. The company primarily operates within a specific region, which may hinder their potential for expansion and global market reach.
- Another weakness is the company's heavy reliance on a few key suppliers. This dependency poses risks in terms of supply chain disruptions and potential price fluctuations, which can impact manufacturing and distribution activities.
Opportunities
- The pharmaceutical industry is continuously growing, presenting numerous opportunities for Formosa Laboratories Inc. The increasing global demand for healthcare products, advancements in technology, and emerging markets offer potential for expansion and diversification.
- Furthermore, strategic collaborations and partnerships with other healthcare companies can provide avenues for expanding their product portfolio and accessing new markets. Formosa Laboratories Inc can leverage these opportunities to enhance their market position and profitability.
Threats
- Formosa Laboratories Inc faces various external threats that could impact their business operations. Intense competition from both established pharmaceutical companies and emerging players poses challenges in terms of market share and pricing pressures.
- Additionally, stringent regulatory requirements and evolving regulations in the pharmaceutical industry can increase compliance burdens and add complexities to the product development and approval process.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.